Jason M. Hafron, MD, CMO

home / authors / jason-m-hafron-md-cmo

Jason Hafron, MD, serves as the Chief Medical Officer at Michigan Institute of Urology.

Articles

Hafron on IsoPSA: A Simpler, Smarter Tool for Prostate Cancer Risk

May 2nd 2025

Jason M. Hafron, MD, discusses IsoPSA, a novel prostate-specific antigen assay for patients with a PSA > 4ng/ml who are facing a decision on prostate biopsy.

Bladder Cancer Takes Center Stage With Breakthrough Advancements at AUA 2025

Mark D. Tyson, II, MD, MPH;Jason M. Hafron, MD, CMO

April 27th 2025

Oncologists at AUA 2025 share promising data, including sasanlimab, cretostimogene grenadenorepvec, and TAR-200 in NMIBC.

$Expert Explores Trials in CIS-Refractory Bladder Cancer$

Expert Explores Trials in CIS-Refractory Bladder Cancer

Jason M. Hafron, MD, CMO

March 12th 2025

Jason M. Hafron, MD, CMO, discusses recent approvals in the non–muscle-invasive bladder cancer space and data from several clinical trials evaluating agents for bladder cancer.